COLL Long Put Strategy
COLL (Collegium Pharmaceutical, Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NASDAQ.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
COLL (Collegium Pharmaceutical, Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $1.13B, a trailing P/E of 14.93, a beta of 0.76 versus the broader market, a 52-week range of 28.339-50.787, average daily share volume of 542K, a public-listing history dating back to 2015, approximately 357 full-time employees. These structural characteristics shape how COLL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.76 places COLL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long put on COLL?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current COLL snapshot
As of May 15, 2026, spot at $33.59, ATM IV 24.10%, IV rank 0.00%, expected move 6.91%. The long put on COLL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long put structure on COLL specifically: COLL IV at 24.10% is on the cheap side of its 1-year range, which favors premium-buying structures like a COLL long put, with a market-implied 1-standard-deviation move of approximately 6.91% (roughly $2.32 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated COLL expiries trade a higher absolute premium for lower per-day decay. Position sizing on COLL should anchor to the underlying notional of $33.59 per share and to the trader's directional view on COLL stock.
COLL long put setup
The COLL long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With COLL near $33.59, the first option leg uses a $33.59 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed COLL chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 COLL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $33.59 | N/A |
COLL long put risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
COLL long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on COLL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use long put on COLL
Long puts on COLL hedge an existing long COLL stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying COLL exposure being hedged.
COLL thesis for this long put
The market-implied 1-standard-deviation range for COLL extends from approximately $31.27 on the downside to $35.91 on the upside. A COLL long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long COLL position with one put per 100 shares held. Current COLL IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on COLL at 24.10%. As a Healthcare name, COLL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to COLL-specific events.
COLL long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. COLL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move COLL alongside the broader basket even when COLL-specific fundamentals are unchanged. Long-premium structures like a long put on COLL are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current COLL chain quotes before placing a trade.
Frequently asked questions
- What is a long put on COLL?
- A long put on COLL is the long put strategy applied to COLL (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With COLL stock trading near $33.59, the strikes shown on this page are snapped to the nearest listed COLL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are COLL long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the COLL long put priced from the end-of-day chain at a 30-day expiry (ATM IV 24.10%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a COLL long put?
- The breakeven for the COLL long put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current COLL market-implied 1-standard-deviation expected move is approximately 6.91%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on COLL?
- Long puts on COLL hedge an existing long COLL stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying COLL exposure being hedged.
- How does current COLL implied volatility affect this long put?
- COLL ATM IV is at 24.10% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.